Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.
Herrlinger U, Rieger J, Koch D, Loeser S, Blaschke B, Kortmann RD, Steinbach JP, Hundsberger T, Wick W, Meyermann R, Tan TC, Sommer C, Bamberg M, Reifenberger G, Weller M.
Herrlinger U, et al. Among authors: steinbach jp.
J Clin Oncol. 2006 Sep 20;24(27):4412-7. doi: 10.1200/JCO.2006.06.9104.
J Clin Oncol. 2006.
PMID: 16983109
Clinical Trial.